SWIRE PACIFIC B(00087) spent 1.704 million Hong Kong dollars on November 14 to repurchase 165,000 shares.
The announcement made by Swire Pacific Limited B (00087) reveals that they spent 1.704 million Hong Kong dollars on November 14, 2024...
SWIRE PACIFIC B (00087) announced that on November 14, 2024, they spent 1.704 million Hong Kong dollars to repurchase 165,000 shares, at a repurchase price of 10.28-10.46 Hong Kong dollars per share.
Related Articles
CMS(00867): Innovative drug high-selective TYK2 inhibitor CMS-D001 received approval for clinical trial notification for ulcerative colitis and Crohn's disease indications.
CICC(03908): CICC Wealth's registered capital will be reduced from 8 billion yuan to 7.173 billion yuan.
On May 25th, Eastroc Beverage (09980) spent 99.95 million yuan to repurchase 683,200 A shares.
CMS(00867): Innovative drug high-selective TYK2 inhibitor CMS-D001 received approval for clinical trial notification for ulcerative colitis and Crohn's disease indications.
CICC(03908): CICC Wealth's registered capital will be reduced from 8 billion yuan to 7.173 billion yuan.
On May 25th, Eastroc Beverage (09980) spent 99.95 million yuan to repurchase 683,200 A shares.
